Health and Healthcare

Acorda Therapeutics Inc : ACOR

All ACOR Articles

42 Articles

Chris Lange | Nov 21, 2016 at 10:04 AM EST

Acorda Slides on Clinical Study Update

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is watching its shares slide on Monday after the company gave an update on a…

Paul Ausick | Sep 26, 2016 at 4:04 PM EDT

Deutsche Bank, Kroger Slip into Monday’s 52-Week Low Club

September 26, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in…

Lee Jackson | Oct 16, 2014 at 8:35 AM EDT

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

In a new report, Stifel analysts highlight their top biotech stocks with strong earnings momentum and possible catalysts to buy…

Lee Jackson | Aug 20, 2014 at 8:40 AM EDT

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

ThinkstockWith the biotech space having its usual volatile ups and downs this year, the analysts at Stifel have stepped back…

Trey Thoelcke | Jan 22, 2014 at 9:05 AM EST

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Here are some of the top biotech names to buy at Cowen. They presented such an extensive list that we…

Jon C. Ogg | Jul 12, 2013 at 8:15 AM EDT

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that…

Paul Ausick | Oct 2, 2012 at 8:38 AM EDT

PetSmart Joins S&P 500

S&P Dow Jones has announced that it will replace oil and gas company Sunoco Inc. (NYSE: SUN) on the S&P…

Jon C. Ogg | Feb 17, 2012 at 8:09 AM EST

Top Analyst Upgrades & Downgrades (ACOR, MT, BBBY, CHK, CLF, CMCSA, DELL, EMN, EPD, LEAP, PBR, RL, VLO, WYNN, ZNGA)

Jon OggThese are some of this Friday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Acorda Therapeutics,…

Jon C. Ogg | May 23, 2011 at 8:22 AM EDT

Top Analyst Upgrades & Downgrades (ACOR, BP, ED, FICO, BEN, GPS, IRBT, KMP, LDK, LTD, ERIC, MXIM, MRGE, MOS, OVTI, PNK)

Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday…

Douglas A. McIntyre | May 20, 2011 at 8:51 AM EDT

Top Active Trader Alert Stocks (ACOR, BPAX, OPXT, BPOP)

Active traders and day traders have many stocks to choose from this Friday morning. We are tracking news and moves…

Douglas A. McIntyre | Jan 21, 2011 at 8:58 AM EST

Top Active Trader Alert Stocks (ACOR, VVUS)

Active traders and day traders have many stocks to choose from this Friday morning. We are tracking news and moves…

Jon C. Ogg | Dec 29, 2010 at 1:47 PM EST

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

2010 is ending and 2011 is about to begin. It has been a very interesting year for major biotech stocks,…

Jon C. Ogg | Sep 9, 2010 at 1:57 PM EDT

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there…

Jon C. Ogg | Aug 3, 2010 at 8:50 AM EDT

Top Day Trader Alerts (ACOR, ARNA, CTSH, DOW, GENZ, PFE, PG, SOLF, SYKE, TSRX)

There are many stocks on the move this Tuesday morning for day traders and active traders to pick from. We…

Douglas A. McIntyre | Feb 18, 2010 at 8:19 AM EST

Top 10 Analyst Upgrades and Downgrades (ACOR, AGCO, AEO, AU, ANDE, CTXS, DE, ITRI, NTAP, VMW)

These are this Thursday’s top ten analyst upgrades, downgrades, and initiations we have seen from Wall Street research calls this…

1 2 3

Acorda Therapeutics Inc : ACOR

All ACOR Articles

Acorda Slides on Clinical Study Update

Deutsche Bank, Kroger Slip into Monday’s 52-Week Low Club

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

PetSmart Joins S&P 500

Top Analyst Upgrades & Downgrades (ACOR, MT, BBBY, CHK, CLF, CMCSA, DELL, EMN, EPD, LEAP, PBR, RL, VLO, WYNN, ZNGA)

Top Analyst Upgrades & Downgrades (ACOR, BP, ED, FICO, BEN, GPS, IRBT, KMP, LDK, LTD, ERIC, MXIM, MRGE, MOS, OVTI, PNK)

Top Active Trader Alert Stocks (ACOR, BPAX, OPXT, BPOP)

Top Active Trader Alert Stocks (ACOR, VVUS)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Day Trader Alerts (ACOR, ARNA, CTSH, DOW, GENZ, PFE, PG, SOLF, SYKE, TSRX)

Top 10 Analyst Upgrades and Downgrades (ACOR, AGCO, AEO, AU, ANDE, CTXS, DE, ITRI, NTAP, VMW)

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

JNK’s 0.40% Fee Quietly Costs You $6,000 Over 20 Years

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Acorda Therapeutics Inc : ACOR

All ACOR Articles

Acorda Slides on Clinical Study Update

Deutsche Bank, Kroger Slip into Monday’s 52-Week Low Club

Analyst Top Biotech Stocks Could Explode After Huge Sell-Off

6 Biotech Stocks to Buy Now With Up to 100% Upside Potential

Cowen Top Biotech Stocks to Buy for 2014 With Huge Upside

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

PetSmart Joins S&P 500

Top Analyst Upgrades & Downgrades (ACOR, MT, BBBY, CHK, CLF, CMCSA, DELL, EMN, EPD, LEAP, PBR, RL, VLO, WYNN, ZNGA)

Top Analyst Upgrades & Downgrades (ACOR, BP, ED, FICO, BEN, GPS, IRBT, KMP, LDK, LTD, ERIC, MXIM, MRGE, MOS, OVTI, PNK)

Top Active Trader Alert Stocks (ACOR, BPAX, OPXT, BPOP)

Top Active Trader Alert Stocks (ACOR, VVUS)

Big Biotech: Best of 2010, Outlook in 2011 (ILMN, ITMN, INCY, THRX, VPHM, DNDN, AMGN, GILD, CELG, HGSI, ACOR)

BioHealth Business Daily, Major News Breaks (QCOR, DNDN, GERN, STEM, ASTM, CYTX, NBS, BTIM, PSTI, SVA, VVUS, OREX, ARNA, SNTS, GENZ, SNY, TEVA, AMGN, ACOR, CELG, HGSI, BIIB, GILD, EXAS, ZGEN, DYAX, IDXX, VPHM)

Top Day Trader Alerts (ACOR, ARNA, CTSH, DOW, GENZ, PFE, PG, SOLF, SYKE, TSRX)

Top 10 Analyst Upgrades and Downgrades (ACOR, AGCO, AEO, AU, ANDE, CTXS, DE, ITRI, NTAP, VMW)

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

JNK’s 0.40% Fee Quietly Costs You $6,000 Over 20 Years

Featured Reads

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance